Producers face decisions that could mean the difference between manageable losses and significant mortalities.

A gibbous moon hangs over a lonely mountain trail in the Italian Alps, above the village of Malles Venosta, whose lights dot the valley below. Benjamin Wiesmair stands next to a moth trap as tall as ...

The presentation will feature the first clinical results for ART6043 from the Phase 1/2a study ( NCT05898399 ), including safety, tolerability, pharmacokinetics, and preliminary efficacy in patients ...

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...

HBcAb-positive, HBsAg-negative people with HIV can safely switch from tenofovir-containing ART without clinically significant ...

Twisted graphene precisely aligned with gold nanodisks and coupled with CRISPR achieves attomolar detection of cancer ...

There are only three antivirals authorized by the US Food and Drug Administration (FDA) for treating COVID-19. If the ...

Researchers have unveiled a new DNA-based therapy that silences the PCSK9 gene to lower cholesterol without statin side effects. Early results show dramatic reductions in cholesterol levels, offering ...

Primases are essential components of the DNA replication apparatus in every organism. They catalyze the synthesis of oligoribonucleotides on single-stranded DNA, which subsequently serve as primers ...

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...